documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

1,123 rows where document_type = "Other" and posted_year = 2003 sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: posted_month, open_for_comment, posted_date (date), comment_start_date (date), last_modified (date)

posted_year 1

  • 2003 · 1,123 ✖

document_type 1

  • Other · 1,123 ✖

agency_id 1

id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2003-P-0177-0001 FDA Warning Label for all Food Products Which Contain Gluten FDA-2003-P-0177 Acknowledgment Letter from FDA DMB to Stockbridge Family Medicine Other Acknowledgement Letter/Receipt 2003-12-29T05:00:00Z 2003 12     2024-10-11T15:15:33Z   0 0 0900006480489c44
FDA-2003-P-0409-0001 FDA Regulatory limit for Listeria monocytogenes in ready-to-eat foods that do not support its growth FDA-2003-P-0409 HFA-305 to Hogan & Hartson L.L.P. Other ACK-Acknowledgement Letter 2003-12-24T05:00:00Z 2003 12     2008-04-12T01:13:30Z   0 0 09000064804a1b19
FDA-1994-P-0041-0231 FDA Require Labeling of Trans Fatty Acid & Prohibit Deceptive Claims-CLOSED FDA-1994-P-0041 HFC-1 to CSPI Other PAV-Petition Approval 2003-12-24T05:00:00Z 2003 12     2008-05-16T23:19:32Z   0 0 09000064804ff056
FDA-2002-P-0082-0001 FDA ANDA Sutability for Albuterol Base Inhalation Solution-CLOSED FDA-2002-P-0082 Petition Denial from FDA CDER to SensorMedics Corporation Other PDN-Petition Denial 2003-12-23T05:00:00Z 2003 12     2024-08-27T13:59:44Z   0 0 090000648048d94e
FDA-2003-P-0126-0002 FDA Requesting the Agency to Permit the Fling of an ANDA for A Drug Product (1.5 mg Levonorgestrel Tablet) Which is Not Indentical to the Reference Listed Drug (Plan B 0.75 mg Levonorgestrel Tablet) In Strength-CLOSED FDA-2003-P-0126 Petition Denial from FDA CDER to HRA Pharma Other PDN-Petition Denial 2003-12-23T05:00:00Z 2003 12 2003-12-17T05:00:00Z   2024-10-17T21:12:42Z   0 0 09000064804861cf
FDA-2003-N-0161-0046 FDA Obesity and Nutrition FDA-2003-N-0161 Exploring the Link Between Food Labeling and Weight Management Other SUP-Supplement 2003-12-23T05:00:00Z 2003 12     2008-04-12T00:59:07Z   0 0 090000648048819d
FDA-2003-N-0161-0037 FDA Obesity and Nutrition FDA-2003-N-0161 Exploring the Link Between Food Labeling and Weight Management Other SUP-Supplement 2003-12-23T05:00:00Z 2003 12     2008-04-12T00:59:01Z   0 0 0900006480488178
FDA-2003-N-0161-0053 FDA Obesity and Nutrition FDA-2003-N-0161 Exploring the Link Between Food Labeling and Weight Management Other SUP-Supplement 2003-12-23T05:00:00Z 2003 12     2008-04-12T00:59:04Z   0 0 09000064804881b4
FDA-2003-N-0161-0041 FDA Obesity and Nutrition FDA-2003-N-0161 Exploring the Link Between Food Labeling and Weight Management Other SUP-Supplement 2003-12-23T05:00:00Z 2003 12     2008-04-12T00:59:07Z   0 0 0900006480488186
FDA-2003-N-0161-0040 FDA Obesity and Nutrition FDA-2003-N-0161 Exploring the Link Between Food Labeling and Weight Management Other SUP-Supplement 2003-12-23T05:00:00Z 2003 12     2008-04-12T00:59:07Z   0 0 0900006480488183
FDA-2003-P-0077-0004 FDA ANDA Suitability Petition for Clarithromycin Extended-Release Tablets-CLOSED FDA-2003-P-0077 HFD-600 to The Weinberg Group Inc Other PAV-Petition Approval 2003-12-23T05:00:00Z 2003 12     2008-04-12T01:10:53Z   0 0 09000064804829c8
FDA-2003-N-0161-0052 FDA Obesity and Nutrition FDA-2003-N-0161 Exploring the Link Between Food Labeling and Weight Management Other SUP-Supplement 2003-12-23T05:00:00Z 2003 12     2008-04-12T00:59:08Z   0 0 09000064804881b1
FDA-2003-N-0161-0035 FDA Obesity and Nutrition FDA-2003-N-0161 Exploring the Link Between Food Labeling and Weight Management Other SUP-Supplement 2003-12-23T05:00:00Z 2003 12     2008-04-12T00:59:01Z   0 0 090000648048816c
FDA-2003-N-0161-0048 FDA Obesity and Nutrition FDA-2003-N-0161 Exploring the Link Between Food Labeling and Weight Management Other SUP-Supplement 2003-12-23T05:00:00Z 2003 12     2008-04-12T00:59:00Z   0 0 09000064804881a4
FDA-2003-N-0161-0038 FDA Obesity and Nutrition FDA-2003-N-0161 Exploring the Link Between Food Labeling and Weight Management Other SUP-Supplement 2003-12-23T05:00:00Z 2003 12     2008-04-12T00:59:06Z   0 0 090000648048817d
FDA-2003-N-0161-0031 FDA Obesity and Nutrition FDA-2003-N-0161 FDA and the Office of Assistant Secretary of Planning and Evaluation - "Exploring the Link Between Weight Management and Food Labels and Packaging, November 20, 2003" - Supplement Other SUP-Supplement 2003-12-23T05:00:00Z 2003 12     2009-11-21T23:28:52Z   0 0 0900006480488156
FDA-2003-N-0161-0034 FDA Obesity and Nutrition FDA-2003-N-0161 Exploring the Link Between Food Labeling and Weight Management Other SUP-Supplement 2003-12-23T05:00:00Z 2003 12     2008-04-12T00:58:59Z   0 0 0900006480488168
FDA-2003-N-0161-0036 FDA Obesity and Nutrition FDA-2003-N-0161 Exploring the Link Between Food Labeling and Weight Management Other SUP-Supplement 2003-12-23T05:00:00Z 2003 12     2008-04-12T00:59:02Z   0 0 0900006480488170
FDA-2003-N-0161-0050 FDA Obesity and Nutrition FDA-2003-N-0161 Exploring the Link Between Food Labeling and Weight Management Other SUP-Supplement 2003-12-23T05:00:00Z 2003 12     2008-04-12T00:59:00Z   0 0 09000064804881ab
FDA-2003-N-0161-0043 FDA Obesity and Nutrition FDA-2003-N-0161 Exploring the Link Between Food Labeling and Weight Management Other SUP-Supplement 2003-12-23T05:00:00Z 2003 12     2008-04-12T00:59:08Z   0 0 0900006480488191
FDA-2003-N-0161-0047 FDA Obesity and Nutrition FDA-2003-N-0161 Exploring the Link Between Food Labeling and Weight Management Other SUP-Supplement 2003-12-23T05:00:00Z 2003 12     2008-04-12T00:58:59Z   0 0 09000064804881a1
FDA-2003-N-0161-0049 FDA Obesity and Nutrition FDA-2003-N-0161 Exploring the Link Between Food Labeling and Weight Management Other SUP-Supplement 2003-12-23T05:00:00Z 2003 12     2008-04-12T00:59:01Z   0 0 09000064804881a8
FDA-2003-N-0161-0042 FDA Obesity and Nutrition FDA-2003-N-0161 Exploring the Link Between Food Labeling and Weight Management Other SUP-Supplement 2003-12-23T05:00:00Z 2003 12     2008-04-12T00:59:01Z   0 0 0900006480488189
FDA-2003-N-0161-0039 FDA Obesity and Nutrition FDA-2003-N-0161 Exploring the Link Between Food Labeling and Weight Management Other SUP-Supplement 2003-12-23T05:00:00Z 2003 12     2008-04-12T00:59:07Z   0 0 0900006480488180
FDA-2003-P-0116-0005 FDA Reclassify Cyclosporine (CSA) as Non-antibiotic Drug-CLOSED FDA-2003-P-0116 HF-22 to Fish & Richardson, PC and Arnold & Porter Other PDN-Petition Denial 2003-12-23T05:00:00Z 2003 12     2008-04-12T01:10:57Z   0 0 090000648048540d
FDA-2003-P-0013-0001 FDA ANDA suitability for carbamazepine tablets, 100mg, 300mg,400-CLOSED FDA-2003-P-0013 Petition Approval Letter from FDA CDER to Taro Pharmaceuticals, U.S.A., Inc. Other PAV-Petition Approval 2003-12-23T05:00:00Z 2003 12 2003-12-22T05:00:00Z   2024-10-07T20:33:42Z   0 0 090000648048129e
FDA-2003-N-0161-0044 FDA Obesity and Nutrition FDA-2003-N-0161 Exploring the Link Between Food Labeling and Weight Management Other SUP-Supplement 2003-12-23T05:00:00Z 2003 12     2008-04-12T00:59:01Z   0 0 0900006480488195
FDA-2003-N-0161-0051 FDA Obesity and Nutrition FDA-2003-N-0161 Exploring the Link Between Food Labeling and Weight Management Other SUP-Supplement 2003-12-23T05:00:00Z 2003 12     2008-04-12T00:59:08Z   0 0 09000064804881ae
FDA-2003-N-0161-0045 FDA Obesity and Nutrition FDA-2003-N-0161 Exploring the Link Between Food Labeling and Weight Management Other SUP-Supplement 2003-12-23T05:00:00Z 2003 12     2008-04-12T00:59:08Z   0 0 0900006480488199
FDA-2003-Q-0080-0003 FDA Qualified Health Claim: Monounsaturated Fatty Acids & Reduced Risk of Coronary Heart Disease FDA-2003-Q-0080 FDA/CFSAN to Nutrition Solutions Other LET-Letter 2003-12-19T05:00:00Z 2003 12     2009-03-10T16:13:57Z   0 0 0900006480482da7
FDA-2003-V-0360-0001 FDA Laser Light Show FDA-2003-V-0360 HFA-305 to True Lasers LLC. Other ACK-Acknowledgement Letter 2003-12-19T05:00:00Z 2003 12     2008-04-12T01:14:58Z   0 0 0900006480497c4a
FDA-2003-Q-0080-0002 FDA Qualified Health Claim: Monounsaturated Fatty Acids & Reduced Risk of Coronary Heart Disease FDA-2003-Q-0080 Acknowledgement Letter [FDA/CFSAN] to North American Olive Oil Association Other ACK-Acknowledgement Letter 2003-12-19T05:00:00Z 2003 12     2009-04-17T20:45:09Z   0 0 0900006480482da6
FDA-2003-Q-0080-0001 FDA Qualified Health Claim: Monounsaturated Fatty Acids & Reduced Risk of Coronary Heart Disease FDA-2003-Q-0080 FDA/CFSAN - Memorandum of Telephone Conversation Other MT-Memorandum of Telephone Conversation 2003-12-19T05:00:00Z 2003 12     2009-04-17T20:44:22Z   0 0 0900006480482cfa
FDA-2003-P-0116-0004 FDA Reclassify Cyclosporine (CSA) as Non-antibiotic Drug-CLOSED FDA-2003-P-0116 HFD-5 to Fish & Richardson and Arnold & Porter Other LET-Letter 2003-12-18T05:00:00Z 2003 12     2008-04-12T01:10:58Z   0 0 090000648048540a
FDA-2003-P-0007-0003 FDA determine whether Lexapro (escitalopram oxalate) tablets 5 mg (NDA 21-323, Product 001),manufactured by Forest laboratories, have been withdrawn or withheld from sale for safety or efficacy reasons FDA-2003-P-0007 Letter from FDA CDER to Lachman Consultant Services, Inc. Other LET-Letter 2003-12-18T05:00:00Z 2003 12 2003-12-16T05:00:00Z   2024-10-28T21:19:37Z   0 0 09000064804811b6
FDA-2003-V-0236-0002 FDA Laser Light Show FDA-2003-V-0236 HFZ-300 to Carnaval Night Club Other VRA-Approval for Variance 2003-12-18T05:00:00Z 2003 12     2008-04-12T01:14:33Z   0 0 090000648048e2d4
FDA-2002-N-0233-0084 FDA Bioterrorism; Prior Notice of Imported Food Shipments FDA-2002-N-0233 HF-1 Other M-Memorandum 2003-12-17T05:00:00Z 2003 12     2008-04-12T01:23:44Z   0 0 090000648049880b
FDA-1980-P-0014-0001 FDA EXEMPT CERIUM (R) FROM GMP (CONFIDENTIAL)-CLOSED FDA-1980-P-0014 memo Other M-Memorandum 2003-12-17T05:00:00Z 2003 12     2008-05-30T22:52:54Z   0 0 09000064805b9288
FDA-2003-P-0173-0002 FDA Health Center, be deemed a ' pharmacy of an other health care entity'-CLOSED FDA-2003-P-0173 Petition Approval from FDA Associate Commissioner for Regulatory Affairs to Family Care Health Centers Other PAV-Petition Approval 2003-12-16T05:00:00Z 2003 12 2003-12-10T05:00:00Z   2024-10-28T21:52:51Z   0 0 0900006480489305
FDA-2003-V-0423-0001 FDA Laser Light Show FDA-2003-V-0423 HFA-305 to Rowan University, Department of Physics & Astronomy Other ACK-Acknowledgement Letter 2003-12-16T05:00:00Z 2003 12     2008-04-12T01:15:09Z   0 0 09000064804a1d79
FDA-2003-P-0346-0001 FDA 513(f) Reclassification Petition for In Vitro Diagnostics for Anti-Hepatitis A Virus IgM and Total Antibodies FDA-2003-P-0346 Acknowledgement Letter from FDA DMB to Beckman Coulter, Inc. Other Acknowledgement Letter/Receipt 2003-12-16T05:00:00Z 2003 12 2003-12-16T05:00:00Z   2024-11-25T16:27:06Z   0 0 0900006480496db0
FDA-2003-N-0196-0020 FDA Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2003-N-0196 Response from FDA/CDER to Buchanan Ingersoll Other Answer 2003-12-15T05:00:00Z 2003 12     2014-06-09T21:16:55Z   0 0 090000648048b603
FDA-2003-D-0435-0003 FDA Compliance Policy Guide Sec. 110.310 Prior Notice of Imported Food Under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002 FDA-2003-D-0435 Guidance for FDA and CBP Staff Prior Notice of Imported Food Under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002 - Guidance Other GDL-Guidance (Supporting and Related Materials) 2003-12-15T05:00:00Z 2003 12     2009-03-10T21:06:01Z   0 0 09000064804a2352
FDA-2003-N-0196-0021 FDA Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2003-N-0196 Response from FDA/CDER to North America Cosmetic Division, Symrise Other Answer 2003-12-15T05:00:00Z 2003 12     2014-06-09T21:22:06Z   0 0 090000648048b618
FDA-2003-N-0196-0022 FDA Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2003-N-0196 Response from FDA/CDER to Morgan, Lewis & Bockius LLP Other Answer 2003-12-15T05:00:00Z 2003 12     2014-06-09T21:33:27Z   0 0 090000648048b61e
FDA-2003-P-0238-0006 FDA Allow Importation of Canadian Versions of Drugs That Are Approved to the United States-CLOSED FDA-2003-P-0238 State of Vermont, Agency of Administration Other CP-Citizen Petition 2003-12-12T05:00:00Z 2003 12     2008-04-12T01:12:03Z   0 0 090000648048e562
FDA-2003-P-0238-0007 FDA Allow Importation of Canadian Versions of Drugs That Are Approved to the United States-CLOSED FDA-2003-P-0238 HFA-305 to State of Vermont, Agency of Administration Other ACK-Acknowledgement Letter 2003-12-12T05:00:00Z 2003 12     2008-04-12T01:12:02Z   0 0 090000648048e563
FDA-2003-P-0124-0003 FDA Silicone Gel-filled Breast Implants-CLOSED FDA-2003-P-0124 Acknowledgment Letter from FDA DMB to Worldclient Other Acknowledgement Letter/Receipt 2003-12-12T05:00:00Z 2003 12 2003-12-12T05:00:00Z   2024-11-18T19:38:46Z   0 0 0900006480485f72
FDA-2003-N-0301-0004 FDA Certain Antibiotic New Animal Drug Products and Use Combinations Subject to Listings in New Animal Drug Regulations; Notice of Opportunity for Hearing; Bacitracin methylene disalicylate single-ingredient Type A Medicated articles FDA-2003-N-0301 GCF-1 (Separation of Functions) Other SF-Separation of Functions 2003-12-12T05:00:00Z 2003 12     2008-04-12T01:00:02Z   0 0 0900006480493da7
FDA-2003-N-0102-0005 FDA Certain Antibiotic New Animal Drug Products and Use Combinations Subject to Listings in New Animal Drug Regulations; Notice of Opportunity for Hearing; Oxytetracycline and neomycin fixed-combination Type A medicated articles FDA-2003-N-0102 FDA Office of Chief Counsel to Dockets Management Branch - Separation of Functions Other SF-Separation of Functions 2003-12-12T05:00:00Z 2003 12     2009-08-10T22:37:24Z   0 0 09000064804840c8
FDA-2003-N-0162-0003 FDA Certain Antibiotic New Animal Drug Products and Use Combinations Subject to Listings in New Animal Drug Regulations; Notice of Opportunity for Hearing; Combination drug Type B and Type C medicated feeds for poultry containing bacitracin zinc FDA-2003-N-0162 Memorandum from FDA to FDA DMB Other Separation of Functions 2003-12-12T05:00:00Z 2003 12     2025-03-14T14:27:02Z   0 0 09000064804885ba
FDA-2003-N-0102-0004 FDA Certain Antibiotic New Animal Drug Products and Use Combinations Subject to Listings in New Animal Drug Regulations; Notice of Opportunity for Hearing; Oxytetracycline and neomycin fixed-combination Type A medicated articles FDA-2003-N-0102 FDA/CVM Response to Buchanan Ingersoll - Letter Other LET-Letter 2003-12-12T05:00:00Z 2003 12     2009-08-10T22:38:25Z   0 0 09000064804840c6
FDA-2003-P-0238-0005 FDA Allow Importation of Canadian Versions of Drugs That Are Approved to the United States-CLOSED FDA-2003-P-0238 State of Vermont, Agency of Administration Other CP-Citizen Petition 2003-12-12T05:00:00Z 2003 12     2008-04-12T01:12:03Z   0 0 090000648048e561
FDA-2003-N-0301-0003 FDA Certain Antibiotic New Animal Drug Products and Use Combinations Subject to Listings in New Animal Drug Regulations; Notice of Opportunity for Hearing; Bacitracin methylene disalicylate single-ingredient Type A Medicated articles FDA-2003-N-0301 HFV-1 to Buchanan Ingersoll Other LET-Letter 2003-12-12T05:00:00Z 2003 12     2011-06-16T18:08:21Z   0 0 0900006480493da6
FDA-2003-P-0411-0003 FDA Requesting That The Commissioner of Food & Drugs Stay It's Review of and Decision on Any & All Premarket Applications (PMAs) for Silicone Gel-Filled Breast Implants Until the Actions Described Below Are Taken with Respect to Such Implants-CLOSED FDA-2003-P-0411 Petition Denial from FDA CDRH to National Organization for Women Other PDN-Petition Denial 2003-12-12T05:00:00Z 2003 12 2003-12-04T05:00:00Z   2024-11-14T16:56:06Z   0 0 09000064804a1b9f
FDA-2003-N-0300-0003 FDA Certain Antibiotic New Animal Drug Products and Use Combinations Subject to Listings in New Animal Drug Regulations; Notice of Opportunity for Hearing; Combination drug Type B and Type C medicated feeds for poultry containing nicarbazin FDA-2003-N-0300 Memorandum from FDA to FDA DDM Other Separation of Functions 2003-12-12T05:00:00Z 2003 12     2025-03-13T19:36:08Z   0 0 0900006480493c87
FDA-2003-P-0172-0003 FDA Permission to file ANADA for a generic new animal drug caroprofen which differs from the pioneer product Rimadyl for dogs-CLOSED FDA-2003-P-0172 Correction of Acknowledgment Letter from FDA DMB to Jurox PTY, Limited Other CR-Correction 2003-12-11T05:00:00Z 2003 12 2003-12-12T05:00:00Z   2024-11-21T16:51:21Z   0 0 090000648048921a
FDA-1981-N-0012-0009 FDA OTC Weight Control Drug Products for Human Use FDA-1981-N-0012 HFA-305 to Thompson Medical Company, Inc. Other ACK-Acknowledgement Letter 2003-12-11T05:00:00Z 2003 12     2008-05-30T22:53:09Z   0 0 09000064805ae8d3
FDA-1980-A-0011-0015 FDA Legal Name for Ice Cream Products FDA-1980-A-0011 Acknowledgement Letter from FDA to Bonner, Thompson, O'Connell, Gaynes & Middlekauff Other Acknowledgement Letter/Receipt 2003-12-11T05:00:00Z 2003 12     2022-05-25T19:51:01Z   0 0 09000064805b9247
FDA-2001-P-0120-0001 FDA ANDA for Covera-HS-CLOSED FDA-2001-P-0120 HF-22 to Morgan, Lewis & Bockius LLP Other PDN-Petition Denial 2003-12-10T05:00:00Z 2003 12     2008-04-25T02:23:16Z   0 0 09000064804bc775
FDA-1980-A-0011-0013 FDA Legal Name for Ice Cream Products FDA-1980-A-0011 Flavor & Extract Manufacturers' Association of the United States Other ACK-Acknowledgement Letter 2003-12-10T05:00:00Z 2003 12     2008-05-30T22:53:21Z   0 0 09000064805b9242
FDA-2003-N-0447-0004 FDA Preparation for ICH meetings and ICH 6 Conference in Osaka, Japan, November 9-15, 2003: Public Meeting FDA-2003-N-0447 Transcript of the November 3, 2003 meeting Other Transcript(s) 2003-12-10T05:00:00Z 2003 12     2025-06-16T17:58:11Z   0 0 09000064804a2542
FDA-1978-N-0021-0017 FDA Over-the-Counter (OTC) Laxative FDA-1978-N-0021 Acknowledgment letter from FDA/CDER to C.I.B.A. Consumer Pharmaceuticals Other Acknowledgement Letter/Receipt 2003-12-10T05:00:00Z 2003 12     2016-09-16T13:25:45Z   0 0 090000648055d699
FDA-1995-S-0038-0005 FDA Human Drugs Patent Term Extension & New Patents FDA-1995-S-0038 List as of December 3, 2003 Other LST-List 2003-12-10T05:00:00Z 2003 12     2008-05-16T23:08:25Z   0 0 090000648055b99c
FDA-2003-N-0447-0003 FDA Preparation for ICH meetings and ICH 6 Conference in Osaka, Japan, November 9-15, 2003: Public Meeting FDA-2003-N-0447 Transcript of the November 3, 2003 meeting Other Transcript(s) 2003-12-10T05:00:00Z 2003 12     2025-06-16T17:54:52Z   0 0 09000064804a2541
FDA-2003-P-0229-0002 FDA ANADA Suitability Petition for Ivermectin/Praziquantel Granule/Crumble Anthelmintic for Horses-CLOSED FDA-2003-P-0229 Petition Approval from FDA CVM to Karen A. Sisson Other PAV-Petition Approval 2003-12-10T05:00:00Z 2003 12 2003-12-04T05:00:00Z   2024-11-18T18:14:41Z   0 0 090000648048db25
FDA-2003-P-0182-0003 FDA ANADA Suitability for Ivermectin Hard-Chew Anthelmintic for (non-food) Horses-CLOSED FDA-2003-P-0182 Petition Approval from FDA CVM to Eugene G. Keller,RPh.,FACA Other PAV-Petition Approval 2003-12-10T05:00:00Z 2003 12 2003-12-04T05:00:00Z   2024-11-13T17:08:12Z   0 0 090000648048a306
FDA-2003-Q-0223-0001 FDA Health Claim Notification Based on Authoritative Statement: for Whole Grains & Coronary Heart Disease FDA-2003-Q-0223 FDA/CFSAN Acknowledgement Letter to Kraft Foods North America, Inc. Other ACK-Acknowledgement Letter 2003-12-10T05:00:00Z 2003 12     2009-04-13T15:33:12Z   0 0 090000648048d100
FDA-2003-P-0278-0001 FDA Maintain the Electroconvulsive Therapy Device in Class III for All Indications FDA-2003-P-0278 Acknowledgment Letter from FDA DDM to Committee for Truth in Psychiatry Other Acknowledgement Letter/Receipt 2003-12-10T05:00:00Z 2003 12 2003-12-10T05:00:00Z   2024-11-23T02:00:47Z   0 0 0900006480491b42
FDA-2003-N-0447-0002 FDA Preparation for ICH meetings and ICH 6 Conference in Osaka, Japan, November 9-15, 2003: Public Meeting FDA-2003-N-0447 Transcript of the November 3, 2003 meeting Other Transcript(s) 2003-12-10T05:00:00Z 2003 12     2025-06-16T17:51:58Z   0 0 09000064804a2540
FDA-2003-P-0333-0003 FDA To Regulate Recombinant and any Other Previously Unlicensed Endotoxin Detection Tests for Validation, In-Process and Finished Product Endotoxin Testing of Drugs, Biological Products and Medical Devices in Accordance With the Same Requirements That Have Been Applied to Limulus Amebocyte Lysate (LAL) Endotoxin Detection Tests for the Past 30 years-CLOSED FDA-2003-P-0333 Letter from FDA CBER to Hyman, Phelps & McNamara Other LET-Letter 2003-12-10T05:00:00Z 2003 12 2003-12-08T05:00:00Z   2024-10-23T18:40:43Z   0 0 0900006480495e67
FDA-2003-N-0161-0027 FDA Obesity and Nutrition FDA-2003-N-0161 FDA and the Office of Assistant Secretary of Planning and Evaluation - "Exploring the Link Between Weight Management and Food Labels and Packaging, November 20, 2003" - [Food Labels, Packaging, Restaurants, and Weight Management; Public Workshop; Amendment of Notice] - Transcript Other TR-Transcript 2003-12-10T05:00:00Z 2003 12     2009-11-21T23:24:43Z   0 0 090000648048813a
FDA-2003-Q-0223-0002 FDA Health Claim Notification Based on Authoritative Statement: for Whole Grains & Coronary Heart Disease FDA-2003-Q-0223 FDA/CFSAN to National Academy of Sciences - Letter Other LET-Letter 2003-12-10T05:00:00Z 2003 12     2009-04-13T15:37:28Z   0 0 090000648048d16c
FDA-1980-A-0011-0014 FDA Legal Name for Ice Cream Products FDA-1980-A-0011 Letter from FDA CFSAN to Henry Todd Other Letter(s) 2003-12-10T05:00:00Z 2003 12     2022-05-25T19:48:58Z   0 0 09000064805b9244
FDA-2003-P-0334-0003 FDA Stay the Effective Date of FDA's Determination That Premarket Approval is not Required for a Recombinant Endotoxin Tests Intended for Endotoxin Testing of Human Drugs and Medical Devices; CLOSED: 10/5/2011 FDA-2003-P-0334 Letter from FDA CBER to Hyman, Phelps & McNamara, PC Other LET-Letter 2003-12-10T05:00:00Z 2003 12 2003-12-08T05:00:00Z   2024-10-28T15:15:39Z   0 0 0900006480495f95
FDA-2003-P-0172-0001 FDA Permission to file ANADA for a generic new animal drug caroprofen which differs from the pioneer product Rimadyl for dogs-CLOSED FDA-2003-P-0172 Acknowledgment Letter from FDA DMB to Jurox PTY, Limited Other Acknowledgement Letter/Receipt 2003-12-10T05:00:00Z 2003 12 2003-12-12T05:00:00Z   2024-11-21T16:40:59Z   0 0 09000064804891cb
FDA-2003-P-0172-0002 FDA Permission to file ANADA for a generic new animal drug caroprofen which differs from the pioneer product Rimadyl for dogs-CLOSED FDA-2003-P-0172 Acknowledgment Letter from FDA DMB to Jurox PTY, Limited Other Acknowledgement Letter/Receipt 2003-12-10T05:00:00Z 2003 12 2003-12-12T05:00:00Z   2024-11-21T16:45:47Z   0 0 0900006480489218
FDA-2003-P-0277-0001 FDA New Drug Abbreviated for Citalopram Hydrobromide Capsules-CLOSED FDA-2003-P-0277 Acknowledgment Letter from FDA DMB to Frommer Lawrence & Haug, L.L.P. Other Acknowledgement Letter/Receipt 2003-12-09T05:00:00Z 2003 12 2003-12-09T05:00:00Z   2024-11-21T02:00:51Z   0 0 09000064804919fd
FDA-2003-V-0130-0001 FDA Laser Light Show FDA-2003-V-0130 HFA-305 to Whatergy Inc. Other ACK-Acknowledgement Letter 2003-12-09T05:00:00Z 2003 12     2008-04-12T01:14:12Z   0 0 0900006480486296
FDA-1977-N-0018-0054 FDA Over-the-Counter Internal Analgesic, Antipyretic & Antirheumatic Products: OPEN FDA-1977-N-0018 Memorandum of Meeting Between FDA/CDER and Bayer HealthCare dated November 19, 2003 Other Memorandum 2003-12-09T05:00:00Z 2003 12     2019-02-04T17:13:11Z   0 0 09000064805d99ab
FDA-2003-P-0408-0003 FDA to request the commissioner of Food and Drugs to determine that Lovenox(enoxaparin sodlium),NDA 20-164(90mg/0.6ml)Product Number 006),sponsored by Aventis Pharmaceuticals Inc.(Aventis), was not withdrawn from sale for reasons of safety of effectiveness. FDA-2003-P-0408 Letter from FDA CDER to Olsson, Frank and Weeda, P.C. Other LET-Letter 2003-12-09T05:00:00Z 2003 12 2003-11-24T05:00:00Z   2024-10-22T21:03:14Z   0 0 09000064804a1b08
FDA-2003-P-0277-0002 FDA New Drug Abbreviated for Citalopram Hydrobromide Capsules-CLOSED FDA-2003-P-0277 Acknowledgment Letter from FDA DMB to Frommer Lawrence & Haug, L.L.P. Other Acknowledgement Letter/Receipt 2003-12-09T05:00:00Z 2003 12 2003-12-09T05:00:00Z   2024-11-20T23:20:42Z   0 0 0900006480491a3e
FDA-2003-P-0124-0002 FDA Silicone Gel-filled Breast Implants-CLOSED FDA-2003-P-0124 Petition Denial from FDA CDRH to Chemically Associated Neurological Disorders Other PDN-Petition Denial 2003-12-05T05:00:00Z 2003 12 2003-12-04T05:00:00Z   2024-11-18T19:11:20Z   0 0 0900006480485f63
FDA-2003-V-0192-0001 FDA Laser Light Show FDA-2003-V-0192 HFA-305 to The Ark/Jget Other ACK-Acknowledgement Letter 2003-12-04T05:00:00Z 2003 12     2008-04-12T01:14:28Z   0 0 090000648048afbf
FDA-1992-N-0056-0011 FDA Prescription Drug Marketing Act of 1987, Drug Amds of 1992 FDA-1992-N-0056 Acknowledgement Letter from HFA-305 to Kleinfeld, Kaplan & Becker, LLP Other Acknowledgement Letter/Receipt 2003-12-03T05:00:00Z 2003 12     2016-11-17T15:16:50Z   0 0 090000648052bfd4
FDA-2003-N-0386-0009 FDA Anti-Counterfeit Drug Initiative FDA-2003-N-0386 HFA-305 to Pharmacetucial Distributors Association Other ACK-Acknowledgement Letter 2003-12-03T05:00:00Z 2003 12     2008-04-12T01:08:05Z   0 0 09000064804a0d76
FDA-1988-N-0003-0002 FDA Prescription Drug Marketing Act of 1987; Guideline FDA-1988-N-0003 HFA-305 Other ACK-Acknowledgement Letter 2003-12-03T05:00:00Z 2003 12     2008-05-30T22:52:35Z   0 0 09000064804752af
FDA-1997-S-0006-0039 FDA Dietary Supplements, Courtesy Letters (Letters of Objection) FDA-1997-S-0006 [LET734] - CFSAN/ONLDS to Body Wise International, Inc. - Courtesy Letter Other LET-Letter 2003-12-02T05:00:00Z 2003 12     2013-07-27T21:58:59Z   0 0 09000064805c989a
FDA-2003-V-0419-0001 FDA A Projector for a Laser Light Show FDA-2003-V-0419 HFA-305 to Pulse Other ACK-Acknowledgement Letter 2003-12-02T05:00:00Z 2003 12     2008-04-12T01:15:06Z   0 0 09000064804a1cae
FDA-1997-S-0006-0040 FDA Dietary Supplements, Courtesy Letters (Letters of Objection) FDA-1997-S-0006 [LET735] - CFSAN/ONLDS to LifeSpan Nutrition - Courtesy Letter Other LET-Letter 2003-12-02T05:00:00Z 2003 12     2013-07-27T21:58:59Z   0 0 09000064805c989b
FDA-2003-P-0176-0001 FDA Modify existing food additive regulation with respect to the irradiation of ground beef byproducts FDA-2003-P-0176 HFA-305 Other ACK-Acknowledgement Letter 2003-12-01T05:00:00Z 2003 12     2008-04-12T01:11:31Z   0 0 0900006480489882
FDA-2002-N-0323-0068 FDA Bioterrorism Preparedness; Registration of Food Facilities FDA-2002-N-0323 List that attended the 10/28/03 Satellite Downlink in Cincinnati District Other LST-List 2003-11-28T05:00:00Z 2003 11     2008-04-12T01:25:12Z   0 0 09000064804a0994
FDA-2002-N-0323-0063 FDA Bioterrorism Preparedness; Registration of Food Facilities FDA-2002-N-0323 BT downlink list of attendees in Baton Rouge, LA Other LST-List 2003-11-28T05:00:00Z 2003 11     2008-04-12T01:25:20Z   0 0 09000064804a098b
FDA-2002-N-0323-0061 FDA Bioterrorism Preparedness; Registration of Food Facilities FDA-2002-N-0323 BT downlink list of attendees in Baton Rouge, LA Other LST-List 2003-11-28T05:00:00Z 2003 11     2008-04-12T01:25:20Z   0 0 09000064804a0986
FDA-2002-N-0323-0073 FDA Bioterrorism Preparedness; Registration of Food Facilities FDA-2002-N-0323 List for BT Downlink held in Washington Other LST-List 2003-11-28T05:00:00Z 2003 11     2008-04-12T01:25:29Z   0 0 09000064804a099c
FDA-2002-N-0233-0052 FDA Bioterrorism; Prior Notice of Imported Food Shipments FDA-2002-N-0233 Memphis, TN BT Downsite 10/28/2003 Other LST-List 2003-11-28T05:00:00Z 2003 11     2008-04-12T01:23:47Z   0 0 09000064804987c4
FDA-2002-N-0233-0050 FDA Bioterrorism; Prior Notice of Imported Food Shipments FDA-2002-N-0233 10/28 Satellite Conference Participants Other LST-List 2003-11-28T05:00:00Z 2003 11     2008-04-12T01:23:39Z   0 0 09000064804987bf
FDA-2002-N-0323-0067 FDA Bioterrorism Preparedness; Registration of Food Facilities FDA-2002-N-0323 List that attended the 10/28/03 Satellite Downlink in Cincinnati District Other LST-List 2003-11-28T05:00:00Z 2003 11     2008-04-12T01:25:12Z   0 0 09000064804a0992
FDA-2002-N-0323-0052 FDA Bioterrorism Preparedness; Registration of Food Facilities FDA-2002-N-0323 List for the Minneapolis Formal Downlink on 10/28 Other LST-List 2003-11-28T05:00:00Z 2003 11     2008-04-12T01:25:20Z   0 0 09000064804a0972
FDA-2002-N-0323-0042 FDA Bioterrorism Preparedness; Registration of Food Facilities FDA-2002-N-0323 BT Downlink Registration Other LST-List 2003-11-28T05:00:00Z 2003 11     2008-04-12T01:25:25Z   0 0 09000064804a095e

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);